Literature DB >> 16950039

Management of types III and IV acetabular deficiencies with the longitudinal oblong revision cup.

Antonio Herrera1, Angel Antonio Martínez, Jorge Cuenca, Vicente Canales.   

Abstract

Thirty-five longitudinal oblong revision (LOR) cups were used to reconstruct 29 type III and 6 type IV acetabular defects. Intraoperatively, we considered that cup contact was complete when we achieved a continuous contact between the cup periphery and the acetabular rim. When there were areas with a lack of contact, we considered that the contact was partial or incomplete. All patients were followed up for 4 to 8 years (mean = 6.3 years). At the latest follow-up, 30 cups were stable (85.8%) and 5 had migrated (14.2%). We found a significant relation between incomplete cup contact with the acetabular rim and subsequent failure (P = .042). The abduction angle was significantly increased in the group of unstable cups (P = .032) because of the migration of the acetabular component that became more vertical. Pain, limp, use of walking aids, functional level, and limb-length discrepancy significantly improved postoperatively (P < .0001). The Harris hip score improved from a mean preoperative score of 37 points to that of 79 points (P < .01). This implant showed satisfactory stability at early to midterm follow-up.

Entities:  

Mesh:

Year:  2006        PMID: 16950039     DOI: 10.1016/j.arth.2005.08.026

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  12 in total

1.  Long-term results for minor column allografts in revision hip arthroplasty.

Authors:  Paul T H Lee; Guy Raz; Oleg A Safir; David J Backstein; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

2.  Acetabular revisions using a cementless oblong cup: five to ten year results.

Authors:  R Civinini; A Capone; C Carulli; M Villano; M I Gusso
Journal:  Int Orthop       Date:  2007-01-13       Impact factor: 3.075

Review 3.  [Comparison of different cup revision systems].

Authors:  K Trieb
Journal:  Orthopade       Date:  2009-08       Impact factor: 1.087

4.  Acetabular Defect Reconstruction with Trabecular Metal Augments: Study with Minimum One-year Follow-up.

Authors:  Chirayu Dwivedi; Sandeep Gokhale; Hyun Gon Khim; Jeon Keon Oh; Won Yong Shon
Journal:  Hip Pelvis       Date:  2017-09-06

5.  [Standardized reconstruction of acetabular bone defects using the cranial socket system].

Authors:  Maximilian Rudert; Boris Michael Holzapfel; Florian Kratzer; Reiner Gradinger
Journal:  Oper Orthop Traumatol       Date:  2010-07       Impact factor: 1.154

6.  Acetabular revision arthroplasty using trabecular titanium implants.

Authors:  Boris Steno; Milan Kokavec; Libor Necas
Journal:  Int Orthop       Date:  2014-09-06       Impact factor: 3.075

7.  Novel Acetabular Cup for Revision THA Improves Hip Center of Rotation: A Radiographic Evaluation.

Authors:  Anton Khlopas; Morad Chughtai; Randa K Elmallah; David Hip-Flores; Arthur L Malkani; Steven F Harwin; Michael A Mont; Michael D Ries
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

8.  Acetabular cup positioning in revision total hip arthroplasty with Paprosky type III acetabular defects: Martell radiographic analysis.

Authors:  Ho-Rim Choi; David Anderson; Scott Foster; Matthew Beal; Jo Ann Lee; Christopher Barr; Henrik Malchau; Joseph McCarthy; Young-Min Kwon
Journal:  Int Orthop       Date:  2013-07-24       Impact factor: 3.075

9.  Structural allograft as an option for treating infected hip arthroplasty with massive bone loss.

Authors:  Paul T H Lee; Robert A Clayton; Oleg A Safir; David J Backstein; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

10.  [Acetabular revision surgery with the oblong revision cup : clinical and radiological results of 217 cases].

Authors:  S Fickert; S Pfeiffer; A Walter; K P Günther; W-C Witzleb
Journal:  Orthopade       Date:  2010-05       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.